255 related articles for article (PubMed ID: 2823887)
41. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
Kushner L; Zukin SR; Zukin RS
Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
[TBL] [Abstract][Full Text] [Related]
42. Quantitative characterization of multiple binding sites for phencyclidine and N-allylnormetazocine in membranes from rat and guinea pig brain.
Zhou GZ; Katki AG; Schwarz S; Munson PJ; Rodbard D
Neuropharmacology; 1991 Jul; 30(7):775-86. PubMed ID: 1656309
[TBL] [Abstract][Full Text] [Related]
43. The rat brain phencyclidine (PCP) receptor. A putative K+ channel.
Sorensen RG; Blaustein MP
Biochem Pharmacol; 1988 Feb; 37(3):511-9. PubMed ID: 2447895
[TBL] [Abstract][Full Text] [Related]
44. Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice.
Itzhak Y; Alerhand S
FASEB J; 1989 May; 3(7):1868-72. PubMed ID: 2541039
[TBL] [Abstract][Full Text] [Related]
45. Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline.
Jamieson GA; Agrawal AK; Greco NJ; Tenner TE; Jones GD; Rice KC; Jacobson AE; White JG; Tandon NN
Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):35-9. PubMed ID: 1322125
[TBL] [Abstract][Full Text] [Related]
46. [3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex.
Akunne HC; Reid AA; Thurkauf A; Jacobson AE; de Costa BR; Rice KC; Heyes MP; Rothman RB
Synapse; 1991 Aug; 8(4):289-300. PubMed ID: 1833849
[TBL] [Abstract][Full Text] [Related]
47. Identification and characterization of a high-affinity glutamate-controlled TCP binding site in rat brain postsynaptic densities.
Foucaud B; Gombos G
Eur J Pharmacol; 1990 Dec; 189(6):355-62. PubMed ID: 1981559
[TBL] [Abstract][Full Text] [Related]
48. Anatomic correlation of NMDA and 3H-TCP-labeled receptors in rat brain.
Maragos WF; Penney JB; Young AB
J Neurosci; 1988 Feb; 8(2):493-501. PubMed ID: 2828564
[TBL] [Abstract][Full Text] [Related]
49. Pseudoallosteric modulation by (+)-MK801 of NMDA-coupled phencyclidine binding sites.
Reid AA; Monn JA; Jacobson AE; Rice KC; Rothman RB
Life Sci; 1990; 47(16):PL77-82. PubMed ID: 2174483
[TBL] [Abstract][Full Text] [Related]
50. Identification and properties of phencyclidine-binding sites in nervous tissues.
Vincent JP; Bidard JN; Lazdunski M; Romey G; Tourneur Y; Vignon J
Fed Proc; 1983 Jun; 42(9):2570-3. PubMed ID: 6303860
[TBL] [Abstract][Full Text] [Related]
51. Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites.
Itzhak Y
Life Sci; 1988; 42(7):745-52. PubMed ID: 2893238
[TBL] [Abstract][Full Text] [Related]
52. Regulation of the binding of sigma- and phencyclidine (PCP)-receptor ligands in rat brain membranes by guanine nucleotides and ions.
Itzhak Y; Khouri M
Neurosci Lett; 1988 Feb; 85(1):147-52. PubMed ID: 2834673
[TBL] [Abstract][Full Text] [Related]
53. Autoradiographic study on the pharmacological characteristics of [3H]3-OH-PCP binding sites in rat brain.
Suzuki T; Yamamoto T; Hori T; Baba A; Shiraishi H; Ito T; Piletz JE; Ho IK
Eur J Pharmacol; 1996 Aug; 310(2-3):243-55. PubMed ID: 8884223
[TBL] [Abstract][Full Text] [Related]
54. The low affinity PCP sites in the rat cerebellum not only bind TCP-like but also BTCP-like structures.
Espaze F; Hamon J; Hirbec H; Vignon J; Kamenka JM
Eur J Med Chem; 2000 Mar; 35(3):323-31. PubMed ID: 10785558
[TBL] [Abstract][Full Text] [Related]
55. Modulation of Mg(2+)-dependent [3H]TCP binding by L-glutamate, glycine, and guanine nucleotides in rat cerebral cortex.
Hori T; Yamamoto T; Hatta K; Moroji T
Synapse; 1991 May; 8(1):13-21. PubMed ID: 1678554
[TBL] [Abstract][Full Text] [Related]
56. Kinetic characterization of the phencyclidine-N-methyl-D-aspartate receptor interaction: evidence for a steric blockade of the channel.
Kloog Y; Haring R; Sokolovsky M
Biochemistry; 1988 Feb; 27(3):843-8. PubMed ID: 2835078
[TBL] [Abstract][Full Text] [Related]
57. MPTP lesions of the nigrostriatal dopaminergic projection decrease [3H]1-[1-(2-thienyl)cyclohexyl]piperidine binding to PCP site 2: further evidence that PCP site 2 is associated with the biogenic amine reuptake complex.
Akunne HC; Johannessen JN; de Costa BR; Rice KC; Rothman RB
Neurochem Res; 1992 Mar; 17(3):261-4. PubMed ID: 1320214
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites.
He XS; Raymon LP; Mattson MV; Eldefrawi ME; de Costa BR
J Med Chem; 1993 Apr; 36(9):1188-93. PubMed ID: 8098066
[TBL] [Abstract][Full Text] [Related]
59. Effects of the major metabolite of phencyclidine, the trans isomer of 4-phenyl-4-(1-piperidinyl)cyclohexanol, on [3H]N-(1-[2-thienyl] cyclohexyl)-3,4-piperidine ([3H]TCP) binding and [3H]dopamine uptake in the rat brain.
Baba A; Yamamoto T; Yamamoto H; Suzuki T; Moroji T
Neurosci Lett; 1994 Nov; 182(1):119-21. PubMed ID: 7891876
[TBL] [Abstract][Full Text] [Related]
60. Alterations in rat brain [3H]-TCP binding following chronic phencyclidine administration.
Massey BW; Wessinger WD
Life Sci; 1990; 47(24):PL139-43. PubMed ID: 2176262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
